Sotera Health (SHC)
11.78
-0.02 (-0.17%)
At close: Mar 28, 2025, 3:59 PM
11.79
0.04%
After-hours: Mar 28, 2025, 04:52 PM EDT
Sotera Health Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 46.68M | 38.84M | 21.7M | 72.32M | 36.06M | 29.23M | 6.08M | 31.21M | 32M | 45.11M | 30.54M | 33.66M | 25.66M | 43.21M | 23.45M |
| Product Revenue Growth | +20.19% | +79.02% | -70.00% | +100.57% | +23.35% | +380.79% | -80.52% | -2.46% | -29.06% | +47.73% | -9.27% | +31.13% | -40.60% | +84.25% | n/a |
| Service Revenue | 238.79M | 237.76M | 226.48M | 237.92M | 227.12M | 226.05M | 214.51M | 220.38M | 216.7M | 221.53M | 206.22M | 207.59M | 200.5M | 208.71M | 188.7M |
| Service Revenue Growth | +0.43% | +4.98% | -4.81% | +4.75% | +0.47% | +5.38% | -2.66% | +1.69% | -2.18% | +7.42% | -0.66% | +3.54% | -3.93% | +10.61% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Canada Revenue | 192.05M | 188.74M | 177.88M |
| Canada Revenue Growth | +1.75% | +6.11% | n/a |
| Europe Revenue | 187.54M | 166.03M | 161.81M |
| Europe Revenue Growth | +12.96% | +2.60% | n/a |
| Other Geographical Areas Revenue | 78.73M | 69.9M | 63.89M |
| Other Geographical Areas Revenue Growth | +12.63% | +9.42% | n/a |
| United States Revenue | 590.97M | 579.02M | 527.91M |
| United States Revenue Growth | +2.06% | +9.68% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 62.01M | 52.16M | 51.82M | 39.74M | 54.11M | 60.29M | 61.91M | 65.95M | 57.09M | 63.13M | 59.54M | 51.83M | 44.04M | 49.83M | 52.47M | 53.16M | 45.63M | 42.68M | 37.05M | 37.12M | 44.46M | 31.86M | 31.86M |
| Selling, General, and Administrative Revenue Growth | +18.87% | +0.67% | +30.37% | -26.55% | -10.24% | -2.62% | -6.12% | +15.52% | -9.57% | +6.03% | +14.89% | +17.69% | -11.62% | -5.03% | -1.30% | +16.49% | +6.91% | +15.20% | -0.18% | -16.50% | +39.56% | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |